In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1832 News Items found
Seungjae Lee and Eric Lai
The Secret Life of ALAS1: How a Basic Science Discovery Could Pave the Way for Better siRNA Therapies

New findings by researchers at MSK and their collaborators at the Icahn School of Medicine point to an opportunity to improve therapies that use small RNAs to silence disease-causing genes, potentially including those involved in cancer.
A researcher working in an MSK lab
MSK Research Highlights, December 18, 2024

New MSK research uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT® could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients.
An immunofluorescence image of an aged mouse liver
Top Cancer Research Advances at MSK in 2024

MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.
Amy Speck
Top Cancer Treatment Advances at MSK in 2024

Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators.
Rectal Cancer Disappears After Experimental Use of Immunotherapy, Now an FDA Designated Breakthrough Therapy

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
Support
Nurse practitioner Amy Devigne
MSK Program Keeps a Close Watch on Long-Term Lung Cancer Survivors

An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.
Article
Logo from the annual meeting of the American Society of Hematology.
New MSK Research on Leukemia, Lymphoma, and Myeloma Presented at 2024 Conference

Read highlights of research presented by MSK scientists at the annual ASH meeting.
MSK patient Michael Simien poses with his bicycle in front of a fountain in New York City
This Remarkable MSK Patient Is Living With Two Kinds of Stage 4 Cancer

Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.
At Work
Ivan Maillard
A ‘Matchmaker’ Between the Lab and the Clinic: At Work With Ivan Maillard

A passion for both science and the humanities has informed the life and career of Dr. Ivan Maillard, who was recently selected to lead the Division of Hematologic Malignancies at MSK.
Tammela Lab
Cancer Risk Declines in Old Age, New MSK Research Helps Explain Why

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.